Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Lihui Hou"'
Autor:
Xiaoxuan Zhao, Xiaoling Feng, Xinjie Zhao, Yuepeng Jiang, Xianna Li, Jingyun Niu, Xiaoyu Meng, Jing Wu, Guowang Xu, Lihui Hou, Ying Wang
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundPolycystic ovary syndrome (PCOS) is a complex reproductive endocrine disorder. And metabolic syndrome (MS) is an important bridge for PCOS patients to develop other diseases, such as diabetes and coronary heart disease. Our aim was to study
Externí odkaz:
https://doaj.org/article/68f397ae32234178a7f90f20d1b12db2
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-6 (2018)
Abstract Background Tai Chi is a moderately intense exercise that dates back to ancient China. It has been reported that Tai Chi not only has beneficial effects on metabolic disorders, such as diabetes, cardiovascular diseases and obesity, but also h
Externí odkaz:
https://doaj.org/article/16aa3ee813654dc594601368def3e4c6
Autor:
Qun Zhou, Josephine Kyazike, Ekaterina Boudanova, Michael Drzyzga, Denise Honey, Robert Cost, Lihui Hou, Francis Duffieux, Marie-Priscille Brun, Anna Park, Huawei Qiu
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 672 (2021)
Site-specific antibody conjugations generate homogeneous antibody-drug conjugates with high therapeutic index. However, there are limited examples for producing the site-specific conjugates with a drug-to-antibody ratio (DAR) greater than two, especi
Externí odkaz:
https://doaj.org/article/1d1d4e9bcd2c468c9df96f3a0a831d57
BackgroundPolycystic ovary syndrome (PCOS) is a complex reproductive endocrine disorder. It has highly heterogeneous clinical manifestations which are characterized by biochemical hyperandrogenemia, obesity, insulin resistance, dyslipidemia, anovulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b14d2337c9f3f3b7177750290a14b7
https://doi.org/10.1101/2022.07.14.500077
https://doi.org/10.1101/2022.07.14.500077
Publikováno v:
Folia histochemica et cytobiologica. 60(3)
Abnormal ovarian angiogenesis is a common feature of polycystic ovary syndrome (PCOS), a typical endocrine disorder affecting women of reproductive age. Histone deacetylase 5 (HDAC5) has been documented as a suppressor of angiogenesis. The aim of thi
Autor:
Yan Li, Changle Peng, Meiwei Zhang, Liangzhen Xie, Jinjin Gao, Yingji Wang, Yuanhe Gao, Lihui Hou
Publikováno v:
Evidence-Based Complementary and Alternative Medicine.
Background. Exercise is one of the recommended interventions for polycystic ovary syndrome (PCOS), and current evidence has shown that Tai chi may have favorable effects. The objective of this randomized controlled pilot trial was to study the feasib
Autor:
Ying Wang, Lihui Hou, Xianna Li, Xiaoxuan Zhao, Guowang Xu, Jing Wu, Yuepeng Jiang, Xiaoling Feng, Jingyun Niu, Xinjie Zhao, Xiaoyu Meng
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology
BackgroundPolycystic ovary syndrome (PCOS) is a complex reproductive endocrine disorder. And metabolic syndrome (MS) is an important bridge for PCOS patients to develop other diseases, such as diabetes and coronary heart disease. Our aim was to study
Publikováno v:
Modern China, 1995 Apr 01. 21(2), 205-232.
Externí odkaz:
https://www.jstor.org/stable/189157
Background: Qiling Wenshen Xiaonang Granule (QLWSG), a compound preparation of traditional Chinese medicine, which was recently approved by the National Medical Products Administration for clinical trials of polycystic ovary syndrome (PCOS). It is ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8d5f1d777b915e5cf3e7de7d4e8f01
https://doi.org/10.21203/rs.3.rs-35198/v1
https://doi.org/10.21203/rs.3.rs-35198/v1
Autor:
Michael Drzyzga, Denise M. Honey, Anna Park, Lihui Hou, Marie-Priscille Brun, Huawei Qiu, Qun Zhou, Robert Cost, Francis Duffieux, Ekaterina Boudanova, Josephine Kyazike
Publikováno v:
Pharmaceuticals
Volume 14
Issue 7
Pharmaceuticals, Vol 14, Iss 672, p 672 (2021)
Volume 14
Issue 7
Pharmaceuticals, Vol 14, Iss 672, p 672 (2021)
Site-specific antibody conjugations generate homogeneous antibody-drug conjugates with high therapeutic index. However, there are limited examples for producing the site-specific conjugates with a drug-to-antibody ratio (DAR) greater than two, especi